Alpha 2.0
Login Register
» Articles » PMID: 7979306

Activity of Clinafloxacin Against Multidrug-resistant Enterococcus Faecium

Overview
Journal Antimicrob Agents Chemother
Publisher American Society for Microbiology
Specialty Pharmacology
Date 1994 Jul 1
PMID 7979306
Citations 4
Authors
S Burney
D Landman
J M Quale
Affiliations
Soon will be listed here.
Abstract

Enterococci resistant to ampicillin, vancomycin, and/or aminoglycosides are a growing clinical problem. We studied the in vitro activity of the new fluoroquinolone clinafloxacin (PD 127,391) against 15 clinical isolates of multidrug-resistant Enterococcus faecium. In kill-kinetic studies, clinafloxacin (1 microgram/ml) was bactericidal against 7 of 12 susceptible isolates, although substantial regrowth occurred in 4 isolates at 48 h. The addition of ampicillin (20 micrograms/ml) resulted in bactericidal activity in all 12 isolates, and no regrowth was seen. For three isolates resistant to clinafloxacin, effective killing was not observed at these concentrations of antibiotics. Clinafloxacin with ampicillin shows promising activity against many of these multiply resistant enterococci.

Citing Articles

Vancomycin-resistant enterococci.

Cetinkaya Y, Falk P, Mayhall C Clin Microbiol Rev. 2000; 13(4):686-707.

PMID: 11023964 PMC: 88957. DOI: 10.1128/CMR.13.4.686.

In vitro activities of an investigational quinolone, glycylcycline, glycopeptide, streptogramin, and oxazolidinone tested alone and in combinations against vancomycin-resistant Enterococcus faecium.

Mercier R, Penzak S, Rybak M Antimicrob Agents Chemother. 1997; 41(11):2573-5.

PMID: 9371372 PMC: 164167. DOI: 10.1128/AAC.41.11.2573.

Current perspectives on glycopeptide resistance.

Woodford N, Johnson A, Morrison D, Speller D Clin Microbiol Rev. 1995; 8(4):585-615.

PMID: 8665471 PMC: 172877. DOI: 10.1128/CMR.8.4.585.

In vitro and in vivo activities of clinafloxacin, CI-990 (PD 131112), and PD 138312 versus enterococci.

Cohen M, Yoder S, Huband M, Roland G, Courtney C Antimicrob Agents Chemother. 1995; 39(9):2123-7.

PMID: 8540728 PMC: 162893. DOI: 10.1128/AAC.39.9.2123.

References
1.
Fernandez-Guerrero M, Rouse M, Henry N, GERACI J, Wilson W . In vitro and in vivo activity of ciprofloxacin against enterococci isolated from patients with infective endocarditis. Antimicrob Agents Chemother. 1987; 31(3):430-3. PMC: 174745. DOI: 10.1128/AAC.31.3.430. View
2.
Norrby S, Jonsson M . Comparative in vitro activity of PD 127,391, a new fluorinated 4-quinolone derivative. Antimicrob Agents Chemother. 1988; 32(8):1278-81. PMC: 172394. DOI: 10.1128/AAC.32.8.1278. View
3.
Sahm D, Koburov G . In vitro activities of quinolones against enterococci resistant to penicillin-aminoglycoside synergy. Antimicrob Agents Chemother. 1989; 33(1):71-7. PMC: 171423. DOI: 10.1128/AAC.33.1.71. View
4.
Facklam R, Collins M . Identification of Enterococcus species isolated from human infections by a conventional test scheme. J Clin Microbiol. 1989; 27(4):731-4. PMC: 267406. DOI: 10.1128/jcm.27.4.731-734.1989. View
5.
Karanfil L, Murphy M, Josephson A, Gaynes R, MANDEL L, Hill B . A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit. Infect Control Hosp Epidemiol. 1992; 13(4):195-200. DOI: 10.1086/646509. View